Introduction Type 2 diabetes is increasingly prevalent among youths, necessitating effective treatment options. This clinical trial aimed to evaluate the efficacy and safety of once-weekly dulaglutide, a glucagon-like peptide-1 receptor agonist, in improving glycemic control in youths with type 2 diabetes. The study was designed to assess the impac
145 Reached
Pancytopenia, a rare presentation of hyperthyroidism
830 Reached2 Comments
Complicated case of Osteoarthritis
1849 Reached2 Comments3 Likes
Safe Ramadan Practices during COVID-19 - WHO Guidance
4888 Reached8 Comments3 Likes
Vildagliptin in Reducing Risk of Post-partum Diabetes
2383 Reached7 Comments4 Likes
Managing Amenorrhea in Adolescent girl
2543 Reached5 Comments4 Likes